KATHY BRYANT: Open Payments
NPI 1619277803 · MIDLOTHIAN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,133 in 96 payments from 15 companies in 2025. Trend: 2023 $2,269 · 2024 $1,967 · 2025 $2,133
Food & beverage: $2,133
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $424 |
| Neurocrine BioSciences, Inc. | 10 | $363 |
| Otsuka America Pharmaceutical, Inc. | 12 | $264 |
| Vanda Pharmaceuticals Inc. | 13 | $252 |
| ABBVIE INC. | 20 | $246 |
| HARMONY BIOSCIENCES LLC | 4 | $108 |
| TMS NeuroHealth Centers Inc. | 1 | $97 |
| Lundbeck LLC | 3 | $80 |
| Alkermes, Inc. | 3 | $73 |
| Janssen Pharmaceuticals, Inc | 2 | $50 |
Products named: CAPLYTA, INGREZZA, REXULTI, VRAYLAR, HETLIOZ, FANAPT, WAKIX, TMS NeuroHealth Centers Inc..
Industry payments across VA — which companies pay providers there.
